Characteristics of the included trials (n = 17). حسب Xiaojuan Yang (794374)

الموضوعات:

Boxplot comparing Ct values for HD in flies and clothes. حسب Philippe Ndzomo (17706039)

Statistical details of data presented in Fig 17. حسب Piotr Popik (292215)

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

Cumulative incidence of any cardiovascular diseases in the BIO-cohort vs. the Non-BIO-cohort. حسب Teng-Li Lin (5559284)

الموضوعات:

S1 Data. Bibliometric analysis. S2 Data. Estrogen level analysis. S3 Data. MicroCT quantification. S4 Data. Markers of bone metabolism. حسب Yan She (8639796)

Elevated concentrations of serum MMA among participants with decreased cognitive performance. حسب Yige Liu (11940344)

Table 1_Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer.docx حسب Yong Sun (406434)

Changes in connectivity of the mPFC among responders and non-responders. حسب Karel Joineau (21799908)

Detection of HD in non-human samples. حسب Philippe Ndzomo (17706039)

Data Sheet 2_Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer.pdf حسب Yong Sun (406434)

Data Sheet 1_Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer.zip حسب Yong Sun (406434)

Skin marks is the S1 Fig title. حسب Mercedes Soto-González (20422078)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. حسب Mieke L. M. Bentvelzen (21594442)

GO analysis of genes with decreased expression (<0.5) in <i>pab2</i>Δ. حسب Ziyue Liu (381532)

DDX5 and DDX17 are required for KSHV lytic reactivation. حسب Praneet Kaur Sandhu (21156149)

Annual treatment frequencies in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)

"…These significantly decreased to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0.0, and 3.1 ± 2.8 in the first year; 2.1 ± 2.8, 0.4 ± 1.0, 0, 0.1 ± 0.3, and 2.6 ± 2.8 in the second year; and 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 in the third year (Kruskal–Wallis test, p < 0.001; Dunn’s test, *P < 0.05, **P < 0.01). …"

Inhibition of NEAT1 decreased the miR-204-5p expression and increased Six1 expression. حسب Lei Li (29537)

Annual number of outpatient visits in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)